Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-01

FDA Approved: DOXEPIN — Original Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved Ajanta Pharma USA Inc.'s original application for doxepin (Doxepin), a generic antidepressant/tricyclic used for depression, anxiety, and insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxepin (Doxepin)

Snippet

ORIG AP for DOXEPIN (DOXEPIN)